Clinical studies show modest reductions in triglycerides and LDL cholesterol in certain populations, but outcomes depend on baseline lipid status, medication dosage, and metabolic health markers
Clothes fitting differently, sleeping better, having more energythese are real signs of progress
Anticipated retatrutide uses Obesity In the phase 2 trial of retatrutide published in the New England Journal of Medicine (NEJM), a group of 338 adults with obesity were randomly given either a placebo or one of four different doses of retatrutide: 1 mg, 4 mg, 8 mg, or 12 mg
Probiotic supplementation is generally beneficial for GLP-1 users experiencing constipation, particularly strains like Bifidobacterium lactis BB-12 and Lactobacillus rhamnosus GG that have demonstrated improvements in transit time and stool consistency
This schedule may change once the FDA reviews the final data
In animal experiments, the GLP-1RA liraglutide was found to stimulate the secretion of ANP by increasing the levels of Epac2, which is a downstream target of GLP-1R signaling in cardiomyocytes (132), However, this finding seemed to contradict the results of clinical studies in which no increase was observed in the levels of ANP in healthy people and patients with T2MD
